A Phase 1/2 Study of Oral 5-Azacitidine and Romidepsin in Patients with Lymphoid Malignancies Reveals Promising Activity in Heavily Pretreated Peripheral T-Cell Lymphoma (PTCL)

Lorenzo Falchi; Jennifer Kimberly Lue; Jennifer E. Amengual; Ahmed Sawas; Changchun Deng; Enrica Marchi; Emily Lichtenstein; Karen Khan; Hyea Kim; Laine E. Atkins

doi:10.1182/blood.v130.suppl_1.1515.1515

A Phase 1/2 Study of Oral 5-Azacitidine and Romidepsin in Patients with Lymphoid Malignancies Reveals Promising Activity in Heavily Pretreated Peripheral T-Cell Lymphoma (PTCL)

NobleID: NI8P23W45R59S00
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/4F5EDFF2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4F5EDFF2.svg?ark=w1%2F20260515%2F4F5EDFF2&value=id)](https://nobleid.org/work/w1/20260515/4F5EDFF2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Lorenzo Falchi

Jennifer Kimberly Lue

Claim authorship of this work

A Phase 1/2 Study of Oral 5-Azacitidine and Romidepsin in Patients with Lymphoid Malignancies Reveals Promising Activity in Heavily Pretreated Peripheral T-Cell Lymphoma (PTCL)

NobleID: NI8P23W45R59S00
Persistent link: https://nobleid.org/ark:/48914/w1/20260515/4F5EDFF2

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4F5EDFF2.svg?ark=w1%2F20260515%2F4F5EDFF2&value=id)](https://nobleid.org/work/w1/20260515/4F5EDFF2)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Lorenzo Falchi

Jennifer Kimberly Lue

Claim authorship of this work